Literature DB >> 11067853

Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR-BI).

D J Greene1, J W Skeggs, R E Morton.   

Abstract

The selective uptake of high density lipoprotein (HDL) cholesteryl ester (CE) by the scavenger receptor class B type I (SR-BI) is well documented. However, the effect of altered HDL composition, such as occurs in hyperlipidemia, on this important process is not known. This study investigated the impact of variable CE and triglyceride (TG) content on selective uptake. CE selective uptake by Y1 and HepG2 cells was strongly affected by modification of either the CE or TG content of HDL. Importantly, TG, like CE, was selectively taken up by a dose-dependent, saturable process in these cells. As shown by ACTH up-regulation and receptor overexpression experiments, SR-BI mediated the selective uptake of both CE and TG. With in vitro modified HDLs of varying CE and TG composition, the selective uptake of CE and TG was dependent on the abundance of each lipid within the HDL particle. Furthermore, total selective uptake (CE + TG) remained constant, indicating that these lipids competed for cellular uptake. These data support a novel mechanism whereby SR-BI binds HDL and mediates the incorporation of a nonspecific portion of the HDL lipid core. In this way, TG directly affects the ability of HDL to donate CE to cells. Processes that raise the TG/CE ratio of HDL will impair the delivery of CE to cells via this receptor and may compromise the efficiency of sterol balancing pathways such as reverse cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067853     DOI: 10.1074/jbc.M008725200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Specific oxidized phospholipids inhibit scavenger receptor bi-mediated selective uptake of cholesteryl esters.

Authors:  Mohammad Z Ashraf; Niladri S Kar; Xi Chen; Jaewoo Choi; Robert G Salomon; Maria Febbraio; Eugene A Podrez
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

2.  Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.

Authors:  Jacquelaine Bartlett; Irene M Predazzi; Scott M Williams; William S Bush; Yeunjung Kim; Stephen Havas; Peter P Toth; Sergio Fazio; Michael Miller
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-05-10

Review 3.  Protein mediators of sterol transport across intestinal brush border membrane.

Authors:  J Mark Brown; Liqing Yu
Journal:  Subcell Biochem       Date:  2010

4.  Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.

Authors:  Richard E Morton; Lahoucine Izem
Journal:  J Lipid Res       Date:  2015-01-23       Impact factor: 5.922

Review 5.  Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.

Authors:  Vassilis I Zannis; Angeliki Chroni; Monty Krieger
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

Review 6.  Unraveling the complexities of the HDL lipidome.

Authors:  Anatol Kontush; Marie Lhomme; M John Chapman
Journal:  J Lipid Res       Date:  2013-03-30       Impact factor: 5.922

Review 7.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

8.  Triglyceride-to-HDL cholesterol ratio. Predictive value for CHD severity and new-onset heart failure.

Authors:  Z Yunke; L Guoping; C Zhenyue
Journal:  Herz       Date:  2013-04-17       Impact factor: 1.443

Review 9.  Dyslipidemias in the prevention of cardiovascular disease: risks and causality.

Authors:  Ian Graham; Marie-Therese Cooney; David Bradley; Alexandra Dudina; Zeljko Reiner
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

10.  Role of LCAT and Apo A-I in Newly Diagnosed HIV Patients.

Authors:  Akshata Mirajkar; Shashikant Nikam; Padmaja Nikam; Giridhar Patil
Journal:  Indian J Clin Biochem       Date:  2016-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.